Rafael Gadia
Overview
Explore the profile of Rafael Gadia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraes F, Abreu C, Siqueira G, Haddad C, Degrande F, Hopman W, et al.
Lancet Reg Health Am
. 2023 Feb;
11:100241.
PMID: 36778931
Background: Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage inoperable primary lung cancer. Here we report a thorough description of the prognostic value of pre-SBRT SUVmax for predicting...
2.
Asso R, Mancini A, Palhares D, Junior W, Marta G, da Silva J, et al.
Rep Pract Oncol Radiother
. 2022 Oct;
27(4):593-601.
PMID: 36196425
Background: Patients with brain metastases (BM) live longer due to improved diagnosis and oncologic treatments. The association of volumetric modulated arc therapy (VMAT) and image-guided radiation therapy (IGRT) with brain...
3.
Moraes F, Marta G, Mitera G, Forte D, Pinheiro R, Vieira N, et al.
Nat Med
. 2022 Aug;
28(9):1738-1739.
PMID: 35941378
No abstract available.
4.
Marta G, de Arruda F, Miranda F, Silva A, Neves-Junior W, Mancini A, et al.
Rep Pract Oncol Radiother
. 2021 Nov;
26(5):756-763.
PMID: 34760310
Background: This study aims to assess the clinical outcomes of patients with spine metastases who underwent stereotactic ablative radiation therapy (SABR) as part of their treatment. SABR has arisen as...
5.
Marta G, de Souza T, Silva A, Pereira A, Ferreira Neto D, Asso R, et al.
Curr Oncol
. 2021 Sep;
28(5):3373-3383.
PMID: 34590597
Background: This study aimed to validate the Brazilian version of EORTC CAT Core and compare the Brazilian results with those from the original European EORTC CAT Core validation study. Methods:...
6.
de Almeida Luz M, Guimaraes G, Nardi A, Pompeo A, Sarkis A, Nowier A, et al.
JCO Glob Oncol
. 2021 Apr;
7:523-529.
PMID: 33856894
Purpose: A group of international urology and medical oncology experts developed and completed a survey on prostate cancer (PCa) in developing countries. The results are reviewed and summarized, and recommendations...
7.
Khauli R, Ferrigno R, Guimaraes G, Bulbulan M, Serrano Uson Junior P, Salvajoli B, et al.
JCO Glob Oncol
. 2021 Apr;
7:530-537.
PMID: 33856890
Purpose: To generate and present survey results on important issues relevant to treatment and follow-up of localized and locally advanced, high-risk prostate cancer (PCa) focusing on developing countries. Methods: A...
8.
Baldotto C, Gelatti A, Accioly A, Mathias C, Mascarenhas E, Carvalho H, et al.
Clinics (Sao Paulo)
. 2020 Jun;
75:e2060.
PMID: 32578829
New cases of the novel coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to rise worldwide following the declaration of a pandemic by...
9.
Berlin A, Moraes F, Sanmamed N, Glicksman R, Koven A, Espin-Garcia O, et al.
J Urol
. 2018 Aug;
201(2):284-291.
PMID: 30153435
Purpose: The NCCN Guidelines® recently endorsed a subclassification of intermediate risk prostate cancer into favorable and unfavorable subgroups. However, this subclassification was developed in a treatment heterogeneous cohort. Thus, to...
10.
Abreu C, Moraes F, Miranda F, Siqueira G, Gadia R, Haddad C, et al.
J Glob Oncol
. 2018 Aug;
4:1-8.
PMID: 30085881
Purpose Stereotactic body radiation therapy (SBRT) has emerged as a treatment option for patients with non-small-cell lung cancer (NSCLC). We report the clinical outcomes and toxicity for patients with inoperable...